Poster zum Thema "Diagnostic and Clinical Microbiology"

Zurück
  • P-DCM-001
Evaluation of different capsule staining methods and development of an improved capsule staining in Klebsiella pneumoniae
  • P-DCM-002
Rapid detection and real-time antibiotic susceptibility testing of Klebsiella pneumoniae and Yersinia pestis using recombinant reporter phages
  • P-DCM-003
Phenotypic antibiotic susceptibility testing for last-resort antibiotics based on bacterial nanomotions provides results in two hours
  • P-DCM-004
Recombinant receptor binding proteins of bacteriophages as versatile tools for pathogen detection
  • P-DCM-005
Evaluation of a rapid MALDI-TOF MS-based colistin resistance test in Klebsiella pneumoniae
  • P-DCM-006
Characterisation of PVL-positive Staphylococcus aureus isolates from Saxony and Brandenburg
  • P-DCM-007
Evaluation of different systems for identification and antibiotic susceptibility testing of bacteria directly from blood cultures
  • P-DCM-008
Differentiation of Mycobacterium abscessus complex by Fourier-transform infrared spectroscopy
  • P-DCM-010
Antibacterial activity of monomeric and fibrillar PAP 248-286
  • P-DCM-011
Evaluation of a new prototype interferon-gamma release assay for the determination of T-cell-mediated immunity in tuberculosis
  • P-DCM-012
Comparison of prevalence of the panton-valentin leukocidin gene among clinical and community-acquired staphylococcus aureus strains
  • P-DCM-013
Evaluation of microbiome enrichment and host DNA depletion in human vaginal samples using Oxford Nanopore's adaptive sequencing
  • P-DCM-014
Detection of Francisella tularensis using recombinant reporter fusion proteins
  • P-DCM-015
Improvement of in vitro diagnostics for tick- and louse-borne relapsing fever used for a seroprevalence study in northern Kenya
  • P-DCM-016
Development of Vancomycin-resistant-enterococci rapid detection kit for routine clinical care
  • P-DCM-017
Nanopore sequencing of positive blood cultures for rapid species identification and resistance prediction
  • P-DCM-018
LiquidArray® Mycobacteria direct: Detection of MTBC and NTM directly from patient specimen
  • P-DCM-019
Pharmaceutical Reactive Chlorine-Oxygen Species Exhibit Antimicrobial Effects on Bacteria in Suspension and Bacterial Biofilms
  • P-DCM-020
LiquidArray® MTB-XDR VER 1.0 - a powerful molecular genetic tool for rapid diagnosis of extensively drug-resistant tuberculosis
  • P-DCM-021
Macozinone Revealed: Nanomotion-Based Rapid Phenotypic Evaluation of New Drug Candidate for Mycobacterium tuberculosis Treatment.
  • P-DCM-022
Analytical and Clinical performance evaluation of the FluoroType® MTBDR VER 2.0 with Dual Target Detection of Mycobacterium tuberculosis Complex from Native Sputum and Culture
  • P-DCM-023
Antimicrobial activity of a nitroxoline conjugate against multidrug-resistant human pathogens
  • P-DCM-024
Re-emergence of Respiratory Syncytial Virus in an Adult Patient Population after the Alleviation of Non-Pharmaceutical Interventions (NPI) due to the SARS-CoV-2 Pandemic
  • P-DCM-025
Comparative Evaluation of MALDI-TOF MS-Based Assays for Carbapenemase Detection in Enterobacterales
  • P-DCM-026
Analytical equivalence study of LiquidArray® Gastrointestinal Kit with extraction performed on GenoXtract®
  • P-DCM-027
A fast and economic protein-microarray based approach for serotyping of Salmonella enterica strains.
  • P-DCM-028
Molecular typing of PVL-positive Staphylococcus aureus isolates from clinical samples
  • P-DCM-029
From Shadows to Spotlight: Enhancing Bacterial DNA Detection in Blood Samples through Cutting-Edge Molecular Pre-Amplification
  • P-DCM-030
A simplified and cost-saving workflow for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria directly from positive blood cultures utilizing the lytic properties of the BD BACTEC™ anaerobic BC bottles.
  • P-DCM-031
Direct identification of bacteria from positive blood culture bottles by using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry - a systematic review and meta-analysis
  • P-DCM-032
Rapid antimicrobial susceptibility testing using the RamanBioAssay platform
  • P-DCM-033
Differentiation of a novel, non-core Brucella Isolate from a White`s Tree frog
  • P-DCM-034
Analyzing Antibiotic Prescribing Patterns Following Blood Culture Diagnostics in an Emergency Department Setting: A Monocentric Retrospective Study
  • P-DCM-035
Performance characteristics of the RADI COVID-19 IgG rapid test for SARS-CoV-2 Anti-S IgG detection compared to an ELISA assay
  • P-DCM-036
Characterisation of carbapenem-resistance in carbapenemase-negative Klebsiella pneumoniae for development of an antibody-based rapid detection kit
  • P-DCM-037
Assessment of three MALDI-TOF MS Systems for High-Throughput Microbial Identification in the Setting of Routine Diagnostics
  • P-DCM-038
Efficacy of CorA Against S. aureus and Clinical Strains of CNS
  • P-DCM-039
Ability of two rapid phenotypic AST methods to detect carbapenem-resistance in Gram-negative bacteria directly from positive blood cultures
  • P-DCM-040
Diagnostic performance of two lateral flow assays for measurement of mannan antigen and anti-mannan IgG antibodies in patients with candidemia: a retrospective case-control study